SilverCrest Metals
SILV
Collegium Pharmaceutical
COLL
Halozyme Therapeutics
HALO
Cars.com
CARS
Hutchmed (China)
HCM
US Stock MarketDetailed Quotes
MRNA Moderna
- 40.215
- -0.055-0.14%
Trading Dec 26 15:13 ET
15.48BMarket Cap-6.92P/E (TTM)
40.485High39.240Low2.89MVolume39.550Open40.270Pre Close115.58MTurnover0.83%Turnover RatioLossP/E (Static)384.82MShares170.47052wk High1.30P/B13.96BFloat Cap35.80052wk Low--Dividend TTM347.11MShs Float497.490Historical High--Div YieldTTM3.09%Amplitude11.540Historical Low40.014Avg Price1Lot Size
Moderna Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.81%1.86B | -30.06%221M | -90.91%167M | -64.22%6.75B | -45.37%2.81B | -44.50%1.79B | -93.08%316M | -69.06%1.84B | 6.42%18.88B | -25.90%5.15B |
| Operating revenue | 3.59%1.82B | -37.20%184M | -90.86%167M | -63.81%6.67B | -42.52%2.79B | -43.69%1.76B | -93.53%293M | -69.15%1.83B | 4.30%18.44B | -29.46%4.86B |
| Cost of revenue | -77.06%514M | -84.27%115M | -87.88%96M | -13.35%4.69B | -51.56%929M | 103.73%2.24B | -47.07%731M | -22.12%792M | 106.95%5.42B | 101.47%1.92B |
| Gross profit | 395.37%1.34B | 125.54%106M | -93.21%71M | -84.69%2.06B | -41.69%1.88B | -121.42%-454M | -113.03%-415M | -78.75%1.05B | -10.98%13.46B | -46.12%3.23B |
| Operating expense | -9.44%1.41B | 1.17%1.47B | -5.31%1.34B | 55.98%6.3B | 13.75%1.88B | 63.31%1.56B | 96.75%1.45B | 102.87%1.41B | 121.56%4.04B | 181.26%1.65B |
| Selling and administrative expenses | -36.43%281M | -19.28%268M | -10.16%274M | 36.84%1.55B | 25.33%470M | 58.99%442M | 57.35%332M | 13.81%305M | 99.65%1.13B | 86.57%375M |
| Research and development costs | -1.98%1.14B | 6.36%1.22B | -6.01%1.06B | 47.04%4.85B | 16.10%1.41B | 41.46%1.16B | 61.69%1.15B | 104.15%1.13B | 65.49%3.3B | 86.88%1.21B |
| Other operating expenses | 84.09%-7M | 28.57%-20M | ---- | 75.77%-94M | -96.92%2M | 69.44%-44M | 84.70%-28M | 80.95%-24M | 47.21%-388M | 124.81%65M |
| Operating profit | 96.52%-70M | 27.00%-1.36B | -245.90%-1.27B | -145.00%-4.24B | -99.62%6M | -272.56%-2.01B | -176.30%-1.87B | -108.66%-366M | -29.15%9.42B | -70.79%1.58B |
| Net non-operating interest income expense | 2.11%97M | 15.38%105M | 14.00%114M | 123.98%383M | 25.97%97M | 90.00%95M | 160.00%91M | 1,011.11%100M | 850.00%171M | 305.26%77M |
| Non-operating interest income | -1.90%103M | 6.73%111M | 10.09%120M | 110.50%421M | 18.39%103M | 81.03%105M | 160.00%104M | 626.67%109M | 1,011.11%200M | 1,142.86%87M |
| Non-operating interest expense | -40.00%6M | -53.85%6M | -33.33%6M | 31.03%38M | -40.00%6M | 25.00%10M | 160.00%13M | 50.00%9M | --29M | --10M |
| Other net income (expense) | 85.37%-6M | -177.78%-21M | 66.67%-13M | -437.50%-86M | -1,550.00%-33M | -4,200.00%-41M | 437.50%27M | -457.14%-39M | 44.83%-16M | 89.47%-2M |
| Gain on sale of security | 75.68%-9M | -204.55%-23M | 57.14%-15M | -260.00%-72M | -1,000.00%-22M | -825.00%-37M | 375.00%22M | -483.33%-35M | ---20M | ---2M |
| Other non- operating income (expenses) | 175.00%3M | -60.00%2M | 150.00%2M | -450.00%-14M | ---11M | -180.00%-4M | --5M | -300.00%-4M | 113.79%4M | --0 |
| Income before tax | 101.07%21M | 26.87%-1.28B | -281.97%-1.17B | -141.17%-3.94B | -95.77%70M | -260.89%-1.96B | -170.70%-1.75B | -107.21%-305M | -27.93%9.58B | -69.41%1.66B |
| Income tax | -99.52%8M | 0 | 102.60%10M | -36.36%772M | -177.37%-147M | 860.92%1.67B | -233.21%-369M | -167.13%-384M | 12.00%1.21B | -64.94%190M |
| Net income | 100.36%13M | 7.32%-1.28B | -1,587.34%-1.18B | -156.37%-4.71B | -85.19%217M | -448.03%-3.63B | -162.81%-1.38B | -97.84%79M | -31.47%8.36B | -69.91%1.47B |
| Net income continuous Operations | 100.36%13M | 7.32%-1.28B | -1,587.34%-1.18B | -156.37%-4.71B | -85.19%217M | -448.03%-3.63B | -162.81%-1.38B | -97.84%79M | -31.47%8.36B | -69.91%1.47B |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 100.36%13M | 7.32%-1.28B | -1,587.34%-1.18B | -156.37%-4.71B | -85.19%217M | -448.03%-3.63B | -162.81%-1.38B | -97.84%79M | -31.47%8.36B | -69.91%1.47B |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 100.36%13M | 7.32%-1.28B | -1,587.34%-1.18B | -156.37%-4.71B | -85.19%217M | -448.03%-3.63B | -162.81%-1.38B | -97.84%79M | -31.47%8.36B | -69.91%1.47B |
| Basic earnings per share | 100.31%0.03 | 8.01%-3.33 | -1,635.00%-3.07 | -158.00%-12.33 | -85.04%0.57 | -456.93%-9.53 | -165.23%-3.62 | -97.80%0.2 | -29.86%21.26 | -68.33%3.81 |
| Diluted earnings per share | 100.31%0.03 | 8.01%-3.33 | -1,715.79%-3.07 | -161.28%-12.33 | -84.76%0.55 | -476.68%-9.53 | -169.08%-3.62 | -97.79%0.19 | -28.88%20.12 | -68.02%3.61 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
